Results Among the 62 cases, 24 (39%) were identified as PD-L1 positive, while four (6.45%) and three (4.84%) demonstrated ALK and ROS1 positivity, respectively, highlighting the molecular heterogeneity of lung adenocarcinoma. This evidence concerns the gene CD274 and lung adenocarcinoma.